|
105
|
471
|
6vknA |
Bg505 sosip.v5.2.n241.n289 in complex with rhesus macaque fab rm19r |
|
37
|
146
|
6vknB |
Bg505 sosip.v5.2.n241.n289 in complex with rhesus macaque fab rm19r |
|
25
|
105
|
6vknJ |
Bg505 sosip.v5.2.n241.n289 in complex with rhesus macaque fab rm19r |
|
27
|
120
|
6vknG |
Bg505 sosip.v5.2.n241.n289 in complex with rhesus macaque fab rm19r |
|
38
|
200
|
6oz4L |
Crystal structure of broadly neutralizing antibody n49p6 fab in complex with hiv-1 bg505 sosip.664 env trimer ectodomain. |
|
28
|
143
|
6oz4B |
Crystal structure of broadly neutralizing antibody n49p6 fab in complex with hiv-1 bg505 sosip.664 env trimer ectodomain. |
|
76
|
469
|
6oz4G |
Crystal structure of broadly neutralizing antibody n49p6 fab in complex with hiv-1 bg505 sosip.664 env trimer ectodomain. |
|
35
|
229
|
6oz4H |
Crystal structure of broadly neutralizing antibody n49p6 fab in complex with hiv-1 bg505 sosip.664 env trimer ectodomain. |
|
42
|
144
|
6vn0B |
Bg505 sosip.v4.1 in complex with rhesus macaque fab rm20f |
|
24
|
125
|
6vn0G |
Bg505 sosip.v4.1 in complex with rhesus macaque fab rm20f |
|
30
|
107
|
6vn0J |
Bg505 sosip.v4.1 in complex with rhesus macaque fab rm20f |
|
99
|
469
|
6vn0A |
Bg505 sosip.v4.1 in complex with rhesus macaque fab rm20f |
|
26
|
105
|
6ozcD |
Bg505 sosip.664 with 2g12 fab2 |
|
103
|
465
|
6ozcA |
Bg505 sosip.664 with 2g12 fab2 |
|
28
|
122
|
6ozcC |
Bg505 sosip.664 with 2g12 fab2 |
|
39
|
139
|
6ozcB |
Bg505 sosip.664 with 2g12 fab2 |
|
21
|
110
|
6opaI |
Crystal structure of bovine fab nc-cow1 in complex with hiv-1 bg505 sosip.664, and human fabs 35022 and pgt128 |
|
20
|
130
|
6opaF |
Crystal structure of bovine fab nc-cow1 in complex with hiv-1 bg505 sosip.664, and human fabs 35022 and pgt128 |
|
26
|
112
|
6opaR |
Crystal structure of bovine fab nc-cow1 in complex with hiv-1 bg505 sosip.664, and human fabs 35022 and pgt128 |
|
31
|
168
|
6opaS |
Crystal structure of bovine fab nc-cow1 in complex with hiv-1 bg505 sosip.664, and human fabs 35022 and pgt128 |
|
38
|
144
|
6opaB |
Crystal structure of bovine fab nc-cow1 in complex with hiv-1 bg505 sosip.664, and human fabs 35022 and pgt128 |
|
83
|
473
|
6opaG |
Crystal structure of bovine fab nc-cow1 in complex with hiv-1 bg505 sosip.664, and human fabs 35022 and pgt128 |
|
17
|
132
|
6opaK |
Crystal structure of bovine fab nc-cow1 in complex with hiv-1 bg505 sosip.664, and human fabs 35022 and pgt128 |
|
15
|
51
|
6v4tA |
Mper-tmd of hiv-1 env bound with the entry inhibitor s2c3 |
|
17
|
102
|
6opaJ |
Crystal structure of bovine fab nc-cow1 in complex with hiv-1 bg505 sosip.664, and human fabs 35022 and pgt128 |
|
28
|
240
|
6pwuH |
Structure of full-length, fully glycosylated, non-modified hiv-1 gp160 bound to pg16 fab |
|
36
|
216
|
6pwuL |
Structure of full-length, fully glycosylated, non-modified hiv-1 gp160 bound to pg16 fab |
|
99
|
629
|
6pwuA |
Structure of full-length, fully glycosylated, non-modified hiv-1 gp160 bound to pg16 fab |
|
19
|
97
|
6u0lD |
Asymmetrically open conformational state (class i) of hiv-1 env trimer bg505 sosip.664 in complex with scd4 and e51 fab |
|
18
|
110
|
6u0lJ |
Asymmetrically open conformational state (class i) of hiv-1 env trimer bg505 sosip.664 in complex with scd4 and e51 fab |
|
17
|
132
|
6u0lH |
Asymmetrically open conformational state (class i) of hiv-1 env trimer bg505 sosip.664 in complex with scd4 and e51 fab |
|
19
|
145
|
6u0lX |
Asymmetrically open conformational state (class i) of hiv-1 env trimer bg505 sosip.664 in complex with scd4 and e51 fab |
|
50
|
467
|
6u0lA |
Asymmetrically open conformational state (class i) of hiv-1 env trimer bg505 sosip.664 in complex with scd4 and e51 fab |
|
40
|
229
|
6sneB |
Crystal structure of ln01 fab in complex with an hiv-1 gp41 peptide |
|
48
|
210
|
6sneA |
Crystal structure of ln01 fab in complex with an hiv-1 gp41 peptide |
|
12
|
34
|
6sneJ |
Crystal structure of ln01 fab in complex with an hiv-1 gp41 peptide |
|
17
|
106
|
6dfgJ |
Bg505 md39 sosip trimer in complex with mature bg18 fragment antigen binding |
|
62
|
468
|
6dfhA |
Bg505 md64 n332-gt2 sosip trimer in complex with germline-reverted bg18 fragment antigen binding |
|
13
|
140
|
6dfgB |
Bg505 md39 sosip trimer in complex with mature bg18 fragment antigen binding |
|
20
|
144
|
6dfhB |
Bg505 md64 n332-gt2 sosip trimer in complex with germline-reverted bg18 fragment antigen binding |
|
16
|
106
|
6dfhJ |
Bg505 md64 n332-gt2 sosip trimer in complex with germline-reverted bg18 fragment antigen binding |
|
13
|
128
|
6dfhG |
Bg505 md64 n332-gt2 sosip trimer in complex with germline-reverted bg18 fragment antigen binding |
|
22
|
129
|
6dfgG |
Bg505 md39 sosip trimer in complex with mature bg18 fragment antigen binding |
|
66
|
469
|
6dfgA |
Bg505 md39 sosip trimer in complex with mature bg18 fragment antigen binding |
|
32
|
176
|
6tybC |
Isolation and structure of an antibody that fully neutralizes isolate sivmac239 reveals functional similarity of siv and hiv glycan shields |
|
103
|
350
|
6tybG |
Isolation and structure of an antibody that fully neutralizes isolate sivmac239 reveals functional similarity of siv and hiv glycan shields |
|
37
|
227
|
6tybH |
Isolation and structure of an antibody that fully neutralizes isolate sivmac239 reveals functional similarity of siv and hiv glycan shields |
|
48
|
213
|
6tybL |
Isolation and structure of an antibody that fully neutralizes isolate sivmac239 reveals functional similarity of siv and hiv glycan shields |
|
19
|
108
|
6cm3J |
Bg505 sosip in complex with scd4, 17b, 8anc195 |
|
58
|
467
|
6cm3D |
Bg505 sosip in complex with scd4, 17b, 8anc195 |
